Chengdu Kanghua Biological Products Co Ltd
SZSE:300841

Watchlist Manager
Chengdu Kanghua Biological Products Co Ltd Logo
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Watchlist
Price: 60.79 CNY -7.13% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Chengdu Kanghua Biological Products Co Ltd?
Write Note

Relative Value

The Relative Value of one Chengdu Kanghua Biological Products Co Ltd stock under the Base Case scenario is 123.57 CNY. Compared to the current market price of 60.79 CNY, Chengdu Kanghua Biological Products Co Ltd is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
123.57 CNY
Undervaluation 51%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
66
Median 3Y
7.5
Median 5Y
7.9
Industry
8.1
Forward
4.3
vs History
80
vs Industry
9
Median 3Y
16.8
Median 5Y
18.5
Industry
23
Forward
11.4
vs History
81
vs Industry
12
Median 3Y
35.4
Median 5Y
48.6
Industry
23.4
vs History
49
vs Industry
9
Median 3Y
13.6
Median 5Y
16.6
Industry
27.3
vs History
81
vs Industry
44
Median 3Y
3.6
Median 5Y
4.3
Industry
2.6
vs History
80
vs Industry
59
Median 3Y
7.1
Median 5Y
7.5
Industry
8.1
Forward
4
vs History
80
vs Industry
58
Median 3Y
7.6
Median 5Y
8.1
Industry
9.6
vs History
80
vs Industry
10
Median 3Y
15.9
Median 5Y
17.8
Industry
4.3
Forward
7.7
vs History
80
vs Industry
9
Median 3Y
15.9
Median 5Y
17.8
Industry
3.8
Forward
8.6
vs History
81
vs Industry
12
Median 3Y
32
Median 5Y
45
Industry
6
vs History
45
vs Industry
8
Median 3Y
-40.5
Median 5Y
14.4
Industry
3.8
vs History
85
vs Industry
47
Median 3Y
3.8
Median 5Y
4.5
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Chengdu Kanghua Biological Products Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
8.2B CNY 4.9 14.4 11 11
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Average P/E: 178.9
14.4
72%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Average EV/EBITDA: 16.9
11
96%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Average EV/EBIT: 21.5
11
76%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top